(19)

(11)

EP 4 217 013 A2

(12)

(88) Date of publication A3: 09.06.2022 (43) Date of publication: 02.08.2023 Bulletin 2023/31 (21) Application number: 21814855.9 (22) Date of filing: 23.09.2021

(51) International Patent Classification (IPC):  A61L 26/00(2006.01) (52) Cooperative Patent Classification (CPC): A61L 26/0023; A61L 26/0061; A61L 26/0052; A61L 26/0066; A61L 2300/404; A61L 2300/204; A61L 26/0076   C-Sets: A61L 26/0023, C08L 1/18; A61L 26/0052, C08L 1/18; A61L 26/0052, C08L 5/04; A61L 26/0023, C08L 1/14; (86) International application number: PCT/IB2021/000655 (87) International publication number: WO 2022/064276 (31.03.2022 Gazette 2022/13)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 23.09.2020 US 202063082031 P (71) Applicant: LAVIPHARM S.A. 190 02 Peania Attica (GR)	(72) Inventors: FOTINOS, Spiros 14561 Kifissia, Attica (GR) LIGIA, Panaitescu 12462 Chaidari, Attica (GR) (74) Representative: Curell Suñol S.L.P.  Muntaner 240, 4º 2ª 08021 Barcelona 08021 Barcelona (ES)